Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

[1]  C. Aspord,et al.  Breast cancer instructs dendritic cells to prime interleukin 13–secreting CD4+ T cells that facilitate tumor development , 2007, The Journal of experimental medicine.

[2]  Y. Ou,et al.  [Tumor stem cells and drug resistance]. , 2007, Sheng li ke xue jin zhan [Progress in physiology].

[3]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[4]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[5]  L. Ricci-Vitiani,et al.  Chemotherapy resistance of glioblastoma stem cells , 2006, Cell Death and Differentiation.

[6]  Yoko Yamamoto,et al.  Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles. , 2006, Cancer research.

[7]  Thomas D. Wu,et al.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.

[8]  L. Ricci-Vitiani,et al.  Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells. , 2006, Cancer research.

[9]  F. Finkelman,et al.  Functional Importance of Regional Differences in Localized Gene Expression of Receptors for IL-13 in Murine Gut1 , 2006, The Journal of Immunology.

[10]  N. Maitland,et al.  Prospective identification of tumorigenic prostate cancer stem cells. , 2005, Cancer research.

[11]  D. Elder,et al.  A tumorigenic subpopulation with stem cell properties in melanomas. , 2005, Cancer research.

[12]  S. Bapat,et al.  Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. , 2005, Cancer research.

[13]  Michael Dean,et al.  Tumour stem cells and drug resistance , 2005, Nature Reviews Cancer.

[14]  M. Kornmann,et al.  Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions , 2005, British Journal of Cancer.

[15]  G. Camussi,et al.  Isolation of renal progenitor cells from adult human kidney. , 2005, The American journal of pathology.

[16]  Zang Ai-hua,et al.  Stem Cells,Cancer and Cancer Stem Cells , 2005 .

[17]  D. Gabrilovich.  Mechanisms and functional significance of tumour-induced dendritic-cell defects , 2004, Nature Reviews Immunology.

[18]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[19]  G. Dontu,et al.  Breast cancer, stem/progenitor cells and the estrogen receptor , 2004, Trends in Endocrinology & Metabolism.

[20]  G. Stassi,et al.  IL-4 Protects Tumor Cells from Anti-CD95 and Chemotherapeutic Agents via Up-Regulation of Antiapoptotic Proteins1 , 2004, The Journal of Immunology.

[21]  T. Wynn,et al.  IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Caprilli,et al.  Human colonocytes in primary culture: a model to study epithelial growth, metabolism and differentiation , 1994, International Journal of Colorectal Disease.

[23]  L. Ricci-Vitiani,et al.  Thyroid cancer resistance to chemotherapeutic drugs via autocrine production of interleukin-4 and interleukin-10. , 2003, Cancer research.

[24]  G. Dontu,et al.  In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.

[25]  B. Petersen,et al.  Stem cells in adult tissues. , 2002, Seminars in cell & developmental biology.

[26]  M. Vogelbaum,et al.  IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells. , 2002, Cancer research.

[27]  Scott W. Lowe,et al.  Apoptosis A Link between Cancer Genetics and Chemotherapy , 2002, Cell.

[28]  Taylor Murray,et al.  Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.

[29]  J. Marine,et al.  Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation. , 2000, Genes & development.

[30]  E. Bröcker,et al.  An antagonistic IL-4 mutant prevents type I allergy in the mouse: inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo. , 1998, Journal of immunology.

[31]  J. Kearney,et al.  AC133, a novel marker for human hematopoietic stem and progenitor cells. , 1997, Blood.

[32]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[33]  G. Zurawski,et al.  Receptors for interleukin‐13 and interleukin‐4 are complex and share a novel component that functions in signal transduction. , 1993, The EMBO journal.

[34]  G. Delespesse,et al.  Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression , 1992, The Journal of experimental medicine.

[35]  P. Leder,et al.  A receptor binding domain of mouse interleukin-4 defined by a solid-phase binding assay and in vitro mutagenesis. , 1992, The Journal of biological chemistry.